Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02380859 · ClinicalTrials.gov registry record · NA

Prism Adaptation Treatment of Parkinson's Disease

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT02380859 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02380859, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

Subjects diagnosed with Idiopathic Parkinson's Disease, between ages of 40-85 inclusive, who have been referred for gait training. Since there can be subtle differences in the brain organization of left- and right-handed people that may influence some of the measurements, right handed participants are preferred. However, a left handed participant may be considered. Participants will be randomly assigned to one of two groups to undergo two weeks of twice-daily sessions. Group A receiving goggles fitted with lenses that distort vision and Group B patients receiving sham goggles

Interventions

  • BEHAVIORAL Prism adaptation

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2015-02
Est. Completion 2017-11-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT02380859

The ClinicalTrials.gov registry entry for NCT02380859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Prism adaptation is the first listed.

NCT02380859 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02380859 about?

NCT02380859 is a clinical study titled "Prism Adaptation Treatment of Parkinson's Disease". Subjects diagnosed with Idiopathic Parkinson's Disease, between ages of 40-85 inclusive, who have been referred for gait training. Since there can be subtle differences in the brain organization of left- and right-handed people that may influence some of the measurements, right handed participants a...

What is the current status of trial NCT02380859?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-02. Estimated completion is 2017-11-30.

What interventions are being tested in trial NCT02380859?

The interventions under investigation include: Prism adaptation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02380859?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.